Goldman Sachs Initiates Pharmerica With Neutral By: Benzinga via Benzinga September 11, 2014 at 08:03 AM EDT Analysts at Goldman Sachs initiated coverage on shares of Pharmerica (NYSE: PMC) with a Neutral rating. The target price for ... Read More >>